Fondazione Irccs Istituto Nazionale Dei Tumori, Milano
Clinical trials sponsored by Fondazione Irccs Istituto Nazionale Dei Tumori, Milano, explained in plain language.
-
New program aims to shield smokers from cancer with pill, quit aid, diet, and exercise
Prevention OngoingThis study is testing a comprehensive prevention program for long-term smokers aged 55-75. The program combines low-dose aspirin, a quit-smoking medication, a Mediterranean-style diet, and increased physical activity, along with annual lung scans. The goal is to see if this multi…
Phase: PHASE2 • Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Prevention
Last updated Mar 30, 2026 14:27 UTC
-
Massive national database launched to crack the code on rare inherited colon diseases
Knowledge-focused OngoingThis study is creating a large national registry in Italy to collect information on patients with inherited conditions that cause many polyps in the colon, which can lead to cancer. It aims to understand how these diseases progress, see how well current monitoring and surgical tr…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC
-
AI joins the fight: using scans and blood tests to personalize kidney cancer care
Knowledge-focused OngoingThis study aims to find better ways to match patients with newly diagnosed metastatic kidney cancer to the most effective first treatment. Researchers will collect blood, tumor tissue, and CT scans from 100 patients to look for patterns. They will use computer analysis to try to …
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:40 UTC